Covid Winter Outlook
SPECIAL FEATURE, 21 Sep 2020
19 Sep 2020 – As predicted by SPR months ago based on antibody data, covid infections, hospitalizations and deaths are now increasing again in many European countries. Antibody values are still very low (<5%) in much of Europe and also in large parts of the US. In global hotspots like New York City, IgG antibody values peaked at about 25%, indicating a population exposure above 50%.
Israel has already imposed a second lockdown, Spain has again 25% of its ICU capacity occupied by covid patients, in France covid hospitalizations are increasing rapidly, and in Switzerland contact tracing is already reaching its limits, even though winter season hasn’t even begun. Needless to say, all of these countries have strict (but ineffective) facemask mandates.
Overall, a 1918-like pandemic pattern with a mild spring wave and a stronger autumn/winter wave appears quite likely. On the plus side, covid death rates are now lower than in spring as medical strategies have improved and some of the worst mistakes are avoided.
The single biggest mistake still made by many Western health authorities is ignoring zinc-based early and prophylactic treatment, as recently described by Professor Thomas Borody (“patients turning around within hours”), Dr. Brian Tyson (“every single patient has recovered”), Professor Christian Perronne (“20,000 preventable deaths in France alone”), and many others.
Many traditional media have lost their credibility by vastly exaggerating the risk of covid to the general population, but some of the critics have also lost touch with reality by falsely claiming the pandemic was over (based on PCR data) or by downplaying “long covid” health issues.
SPR will continue to provide unbiased covid facts and keep an eye on political and geopolitical pandemic-related developments.
Swiss Policy Research, founded in 2016, is an independent, nonpartisan and nonprofit research group investigating geopolitical propaganda in Swiss and international media. SPR is composed of independent academics that for personal and professional reasons prefer to protect their identities, and receives no external funding; there are no financial sponsors or backers. Our articles have been published or shared by numerous independent media outlets and journalists, among them Julian Assange, and have been translated into more than two dozen languages.
Tags: Airborne contagion, COVID-19, China, Community, Compassion, Coronavirus, Cuba, Economy, Empathy, Environment, Health, Lockdown, Orthomolecular Medicine, Pandemic, Public Health, Research, Science, Science and Medicine, Swiss Policy Research, United Nations, WHO
DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
Join the discussion!
We welcome debate and dissent, but personal — ad hominem — attacks (on authors, other users or any individual), abuse and defamatory language will not be tolerated. Nor will we tolerate attempts to deliberately disrupt discussions. We aim to maintain an inviting space to focus on intelligent interactions and debates.